List view / Grid view
In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered.
9 July 2015 | By Victoria White
AstraZeneca and EvoRx have successfully completed a one-year research collaboration using EvoRx's Evo-Link technology to discover cell penetrating peptides...
9 July 2015 | By Victoria White
Scientists have shown that didehydro-Cortistatin A reduces residual levels of HIV virus from dormant cells, establishing a near-permanent state of latency...
8 July 2015 | By Victoria White
Pfizer’s Centres for Therapeutic Innovation and the Jeffrey Modell Foundation are to collaborate to conduct research in the field of immunological diseases...
8 July 2015 | By Oxford Global
Oxford Global Conferences are proud to present the Cell & Gene Therapy with our co-located 2nd Annual Stem Cell Congress is taking place on the 9th & 10th of November in London, UK...
7 July 2015 | By Oxford Global
The 2nd Annual Drug Discovery USA Congress is taking place on the 29th & 30th of October 2015 in Boston, USA...
6 July 2015 | By Oxford Global
Oxford Global Conferences are delighted to announce the 2nd Annual Stem Cell Congress with our co-located Cell & Gene Therapy is taking place on the 9th & 10th of November in London, UK..
3 July 2015 | By Victoria White
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective flu vaccines...
30 June 2015 | By Victoria White
Scientists have unravelled a key process in the bacterium that causes TB, potentially paving the way for new antibiotics to fight the disease...
25 June 2015 | By Victoria White
Bristol-Myers Squibb Company has announced important next steps in the evolution of the Company’s R&D organisation...
24 June 2015 | By Victoria White
AYOXXA and Grünenthal have completed a research collaboration to validate detection limits for a biomarker based on AYOXXA’s proprietary technology platform...
Find out about the science behind Affimers - including why Affimers are superior to antibodies and details about our custom Affimer process...
Find out more about the applications of Affimers, including how Affimers can be used in the development of therapeutics...
22 June 2015 | By Victoria White
The Dementia Consortium is funding a new project to target the immune system in the hunt for new treatments for Alzheimer's disease...
High throughput screening (HTS) continues to be employed in drug discovery as the primary source of identifying chemical starting points for drug discovery and tool compounds for chemical biology, respectively. Although small molecule drug discovery efforts have focused largely upon enzyme, receptor and ion-channel targets, there has been an increase…
This video introduces Avacta Life Sciences, part of Avacta Group plc and its flagship product, Affimers - a revolutionary new, engineered alternative to antibodies...
